Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesGeneration of an epigenetic signature by chronic hypoxia in prostate cells
Human Molecular Genetics, 09/14/09
Watson JA et al. – The epigenetic signatures may represent an additional mechanism to promote and maintain a hypoxic–adapted cellular phenotype with a potential role in tumour development.
Related Articles
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Cancer Immunology, Immunotherapy, 10/26/09
Relevance Score: 70%
Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells
The Prostate, 11/18/09
Relevance Score: 69%
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10
The Prostate, 11/18/09
Relevance Score: 69%
Microarray analysis reveals potential target genes of NF-[kappa]B2/p52 in LNCaP prostate cancer cells
The Prostate, 10/15/09
Relevance Score: 69%
Overexpression of hepatocyte nuclear factor-3[alpha] induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells
The Prostate, 10/30/09
Relevance Score: 68%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
Journal of Cancer Research & Clinical Oncology, 12/04/09
Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus
The Prostate, 12/04/09
DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09
Article Search
Sponsor